Basking raises $55M; Seroba’s fourth fund; Vera upsizes its public offering

Plus, news about Abeona Therapeutics and Graviton:

Basking Biosciences raises $55M: The Columbus, OH-based startup reeled in funding from half a dozen investors, including ARCH Venture Partners, whose managing director Steven Gillis will join Basking’s board as chair. The biotech plans to start a Phase II for its RNA aptamer BB-031 in patients with acute ischemic stroke this year. — Kyle LaHucik

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

US Government Invests $50M in Automating Hospital Cybersecurity Defense

What You Should Know: – The healthcare industry faces a growing threat: cyberattacks targeting hospital IT systems. In response, the US government’s Advanced Research Projects

May 25, 2024

Neighborhood environment can increase risk of COVID-19 hospitalization, study reveals

The range of COVID-19 symptoms varies-;some feel a mild cold, others are hospitalized, while others perish. Many studies have linked the severity of COVID-19 symptoms

July 15, 2023

Researchers reveal mechanisms of how CDK12 alterations drive prostate cancer development

When researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate cancer, they knew they needed to understand

October 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.